Oppenheimer Initiates Coverage of Amrize (AMRZ) with Outperform Rating, Cites Growth Strategy, Strong Financials

Amrize (NYSE:AMRZ) is one of the best IPO stocks to buy and hold for 3 years. On September 9, Oppenheimer analyst Bryan F. Blair initiated coverage of Amrize with an Outperform rating and $62 price target. Oppenheimer noted Amrize’s advantaged footprint and resource base, structural pricing power, and sustainable margin generation. The firm also highlighted Amrize’s prospects for double-digit earnings growth through the cycle

Prior to this sentiment, Amrize delivered its Q2 2025 financial results, which reported stable revenues of $3.22 billion. This was a slight decrease from $3.24 billion in Q2 2024. Net income for Q2 2025 was $428 million, or $0.78 per diluted share, down from $473 million, or $0.86 per diluted share, in Q2 2024.

Amrize is pursuing a growth strategy that includes operational improvements, acquisitions, and capital investments. The company launched its ASPIRE program, which aims to generate over $250 million in synergies by 2028. It expects to see savings from this program in H2 2025, with full annual savings beginning in 2026. Amrize also expanded its market presence by acquiring Langley Concrete Group in Canada and opening a new quarry in Oklahoma to serve the Dallas-Fort Worth market.

Amrize (NYSE:AMRZ) focuses on the building materials business in North America. It was incorporated in 2023 and is based in Zug, Switzerland.

While we acknowledge the potential of AMRZ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.